3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
trastuzumab deruxtecan
4
eribulin
3
Capecitabine
3
Trastuzumab
2
Paclitaxel
2
Gemcitabine
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
telisotuzumab vedotin
1
taxane
1
pertuzumab
1
pembrolizumab
1
osimertinib
1
olaparib
1
margetuximab
1
exemestane
1
entrectinib
1
encorafenib
1
dacomitinib
1
capmatinib
1
binimetinib
1
adagrasib
1
abemaciclib
1
Vinorelbine
1
Vemurafenib
1
Pemetrexed
1
Imlunestrant
1
Gefitinib
1
Fulvestrant
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Neoplasm Metastasis
×
trastuzumab biosimilar HLX02
×
Clear all
No trials found.